|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.440 CAD | +0.29% |
|
+13.91% | +27.41% |
| 07-28 | BioRem Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-28 | BioRem Q2 Net Earnings Rise to C$0.11 Per Share | MT |
| Market Cap | 55.79M 39.77M 34.57M 32.18M 29.54M 3.8B 56.65M 379M 149M 1.89B 149M 146M 6.34B | P/E 2026 * |
10.1x | P/E 2027 * | 8x |
|---|---|---|---|---|---|
| Enterprise Value | 55.79M 39.77M 34.57M 32.18M 29.54M 3.8B 56.65M 379M 149M 1.89B 149M 146M 6.34B | EV / Sales 2026 * |
1.07x | EV / Sales 2027 * | 0.95x |
| Free-Float |
97.53% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.29% | ||
| 1 week | +13.91% | ||
| 1 month | +10.26% | ||
| 3 months | +7.50% | ||
| 6 months | +42.15% | ||
| Current year | +27.41% |
| 1 week | 3 |  | 3.62 |
| 1 month | 2.95 | | 3.62 |
| Current year | 2.26 | | 3.62 |
| 1 year | 1.87 | | 3.62 |
| 3 years | 0.81 | | 3.62 |
| 5 years | 0.43 | | 3.62 |
| 10 years | 0.22 | | 3.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Derek Webb
CEO | Chief Executive Officer | - | 17/12/2014 |
Douglas Newman
DFI | Director of Finance/CFO | - | - |
Mark Smit
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Derek Webb
BRD | Director/Board Member | - | 17/12/2014 |
Alex Gill
BRD | Director/Board Member | - | 22/06/2020 |
William White
CHM | Chairman | 74 | 22/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/09/25 | Tax | Company | 20,000 | 0.1241% | ||
| 24/09/25 | Tax | Company | 20,000 | 0.1241% | ||
| 24/09/25 | Tax | Company | 4,600 | 0.0285% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.29% | +13.91% | +59.26% | +265.96% | 39.7M | |
| -0.27% | -16.33% | - | - | 14.61B | |
| +1.71% | +1.56% | +30.94% | +49.99% | 10.74B | |
| +8.86% | -3.04% | +55.51% | +256.74% | 3.89B | |
| +0.53% | -12.88% | +46.59% | +447.26% | 3.83B | |
| +3.58% | -7.92% | +36.74% | +86.66% | 1.2B | |
| +11.12% | -13.85% | - | - | 968M | |
| -0.36% | +3.77% | -19.64% | -18.39% | 913M | |
| +4.73% | -0.97% | +123.33% | +121.78% | 836M | |
| +2.10% | -1.66% | +201.17% | +180.24% | 734M | |
| Average | +3.23% | -5.58% | +66.74% | +173.78% | 3.78B | |
| Weighted average by Cap. | +1.88% | -9.75% | +45.35% | +161.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.1M 37.14M 32.28M 30.05M 27.59M 3.55B 52.91M 354M 139M 1.76B 139M 136M 5.92B | 58.9M 41.99M 36.5M 33.97M 31.19M 4.01B 59.81M 400M 157M 2B 158M 154M 6.69B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | CA$3.440 | +0.29% | 9,364 |
| 30/07/26 | CA$3.430 | -2.00% | 12,080 |
| 29/07/26 | CA$3.500 | -2.51% | 49,468 |
| 28/07/26 | CA$3.590 | +18.48% | 186,976 |
| 27/07/26 | CA$3.030 | +0.33% | 9,893 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.440CAD
Average target price
3.500CAD
Spread / Average Target
+1.74%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BRM Stock
Select your edition
All financial news and data tailored to specific country editions
